Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Wake Forest University Health Sciences: Clinical Trials & FDA Approval Profile

Wake Forest University Health Sciences (Global / Institutional) sponsors 97 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 35 active protocols (26 recruiting now), 24 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)39.2%
Median Closed Enrollment vs National (145 pts)25 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Wake Forest University Health Sciences
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)97
Active Pipeline (Recruiting Now)35 (26)
Completed vs Stopped Early24 / 38 (39.2%)
Median Closed Actual Enrollment25 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Wake Forest University Health Sciences
Hospital Research SiteLocationShared Protocols
Levine Cancer InstituteCharlotte, NC11
Wake Forest University Health SciencesWinston-Salem, NC10
Wake Forest Baptist HealthWinston-Salem, NC8

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Wake Forest University Health Sciences
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05766670Intramedullary Calcium Sulfate Antibiotic DepotPhase IIIRECRUITING
NCT07560826The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed OsteosarcomaPhase IIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Wake Forest University Health Sciences Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI